The Foundation Institute for 21st Century Medicine

The Foundation Institute for 21st Century Medicine, also known as C21Med, is a private Cambridge, U.K.-based life sciences organization launched by Medicxi in 2018. It operates as an "ideas factory" focused on translating scientific insights into novel drug candidates and forming new life science companies rather than advancing a conventional disclosed in-house clinical pipeline. The organization was founded by David Grainger and Richard Mason and was designed to complement Medicxi's venture investing model with early scientific ideation, killer experiments, and capital-efficient company creation. Publicly available information suggests its main output has been venture creation and early therapeutic concept generation across Europe. Because disclosures are limited, specific programs, targets, and indications are not well described in public sources.